Glen Eagle Advisors, LLC Astrazeneca PLC Transaction History

Glen Eagle Advisors, LLC

  • $719 Billion
  • Q3 2025

A detailed history of Glen Eagle Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 290 shares of AZN stock, worth $25,926. This represents 0.0% of its overall portfolio holdings.

Number of Shares
290
Previous 440 34.09%
Holding current value
$25,926
Previous $30.7 Million 27.64%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$68.72 - $82.11 $10,308 - $12,316
-150 Reduced 34.09%
290 $22.2 Million
Q1 2025

May 15, 2025
SELL
$65.37 - $77.96 $9,217 - $10,992
-141 Reduced 24.27%
440 $32.3 Million
Q3 2024

Nov 14, 2024
BUY
$76.67 - $87.62 $536 - $613
7 Added 1.22%
581 $45.3 Million
Q2 2024

Aug 14, 2024
SELL
$66.81 - $80.83 $18,439 - $22,309
-276 Reduced 32.47%
574 $44.8 Million
Q1 2024

Jul 03, 2024
BUY
$61.03 - $69.57 $16,295 - $18,575
267 New
267 $18.1 Million
Q4 2023

Aug 13, 2024
SELL
$61.89 - $69.28 $3,094 - $3,464
-50 Reduced 15.77%
267 $18 Million
Q3 2023

Aug 13, 2024
BUY
$64.85 - $71.7 $1,361 - $1,505
21 Added 7.09%
317 $21.5 Million
Q2 2023

Aug 13, 2024
BUY
$69.91 - $75.81 $69 - $75
1 Added 0.34%
296 $21.1 Million
Q1 2023

Aug 13, 2024
SELL
$63.15 - $71.6 $757 - $859
-12 Reduced 3.91%
295 $20.5 Million
Q4 2022

Aug 13, 2024
BUY
$54.21 - $70.44 $9,595 - $12,467
177 Added 136.15%
307 $20.8 Million
Q3 2022

Aug 13, 2024
BUY
$53.02 - $135.75 $2,491 - $6,380
47 Added 56.63%
130 $7.13 Million
Q2 2022

Aug 13, 2024
SELL
$59.26 - $71.14 $888 - $1,067
-15 Reduced 15.31%
83 $5.48 Million
Q4 2021

Aug 13, 2024
SELL
$54.02 - $63.83 $24,579 - $29,042
-455 Reduced 82.28%
98 $5.71 Million
Q1 2021

Aug 13, 2024
BUY
$47.16 - $54.44 $12,733 - $14,698
270 Added 95.41%
553 $27.5 Million
Q4 2020

Aug 13, 2024
BUY
$48.52 - $58.02 $776 - $928
16 Added 5.99%
283 $14.1 Million
Q3 2020

Aug 13, 2024
BUY
$53.07 - $61.1 $2,653 - $3,055
50 Added 25.0%
250 $13.7 Million
Q2 2019

Aug 13, 2024
SELL
$37.28 - $41.68 $24,232 - $27,092
-650 Reduced 76.47%
200 $8.26 Million
Q1 2019

Aug 13, 2024
BUY
$35.49 - $43.02 $20,690 - $25,080
583 Added 218.35%
850 $34.4 Million
Q1 2018

Aug 14, 2024
BUY
$32.97 - $36.63 $19,221 - $21,355
583 Added 218.35%
850 $29.7 Million
Q3 2017

Aug 13, 2024
BUY
$28.96 - $34.0 $16,883 - $19,822
583 Added 218.35%
850 $28.8 Million
Q4 2016

Aug 12, 2024
BUY
N/A
733
1,000 $27.3 Million

Others Institutions Holding AZN

# of Institutions
1,499
Shares Held
500M
Call Options Held
5.59M
Put Options Held
3.18M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $277B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Glen Eagle Advisors, LLC Portfolio

Follow Glen Eagle Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glen Eagle Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email